Drug
Clostridium Difficile Vaccine
Clostridium Difficile Vaccine: highest development phase Phase 2, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Clostridium difficile vaccine NCT02117570 | Phase 2 | Clostridium Difficile Associated Disease |
Latest
No recent events.
Follow Clostridium Difficile Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.